Global Sexual Dysfunction Drugs Market 2017-2021

Global Sexual Dysfunction Drugs Market 2017-2021

  • August 2017 •
  • 91 pages •
  • Report ID: 5096212 •
  • Format: PDF
About Sexual Dysfunction Drugs

Sexual dysfunctions include sexual disorders of men and women that can interfere with their sexual performance, leading to unsatisfied sexual intercourse. The major drugs used in this market are PDE5 inhibitors, whereas other drugs such as hormone-related and transurethral also have a presence in the market. Erectile dysfunction (ED) is a highly prevalent sexual dysfunction seen in men. Globally, there has been an increase in the number of ED cases caused due to high blood pressure, obesity, neurological and nerve disorders, prostate cancer, and diabetes among others.

Technavio’s analysts forecast the global sexual dysfunction drugs market to grow at a CAGR of 2.79% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global sexual dysfunction drugs market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• Americas

Technavio’s report, Global Sexual Dysfunction Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• AbbVie
• Bayer
• Eli Lilly
• Pfizer

Other prominent vendors
• Apricus Biosciences
• Emotional Brain
• GlaxoSmithKline
• Ivix LLX
• Leadiant Biosciences
• Merck
• NexMed
• Palatin Technologies and PRA Health Sciences
• S1 Biopharma
• Takeda
• Teva Pharmaceutical Industries
• Trimel Biopharma SRL
• Vietstar Biomedical Research

Market driver
• Rising prevalence of sexual dysfunctions
• For a full, detailed list, view our report

Market challenge
• Technological advancements, a threat to drug therapy
• For a full, detailed list, view our report

Market trend
• Increased focus on generic drugs
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

We are very sorry, but an error occurred.
Please contact if the problem remains.